Join to view full profile
20 Community LaneGordonville, PA 17529
Phone+1 717-687-9407
Fax+1 717-687-9237
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kevin Strauss, MD is a board certified pediatrician in Gordonville, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Delaware, and Indiana. He is affiliated with Nemours Children’s Hospital, Delaware.
Education & Training
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1998 - 2001
Harvard Medical SchoolClass of 1998
Certifications & Licensure
PA State Medical License 2001 - 2026
DE State Medical License 2016 - 2025
IN State Medical License 2016 - 2025
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 8 citationsdigenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease.Jiaming Wang, Laura E Poskitt, Jillian Gallagher, Erik G Puffenberger, R Max Wynn
Science Translational Medicine. 2025-02-26 - 6 citationsPreemptive dual therapy for children at risk for infantile-onset spinal muscular atrophy.Susan E Matesanz, Karlla W Brigatti, Millie Young, Sabrina W Yum, Kevin A Strauss
Annals of Clinical and Translational Neurology. 2024-07-01 - WiTNNess: An international natural history study of infantile-onset TNNT1 myopathy.Kevin A Strauss, Vincent J Carson, Emilienne Bolettieri, Mariah Everett, Ashton Bollinger
Annals of Clinical and Translational Neurology. 2023-11-01
Press Mentions
AAV Gene Therapy for Maple Syrup Urine Disease Shows PromiseMarch 4th, 2025- Gene Therapy Developed for Maple Syrup Urine Disease Shows Promise, New UMass Chan Study ReportsFebruary 28th, 2025
- ASC Therapeutics Announces Partnership with University of Massachusetts Medical School to Co-Develop Novel Gene Therapy for Maple Syrup Urine DiseaseJuly 27th, 2021
